glp1 retatrutide PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Gwyneth Paltrow, Andrew Huberman &

Gradual dose escalation is used to minimise gastrointestinal side effects such as nausea, vomiting, and diarrhoea, which are most common at higher doses

Hepatology (2010) 51:158492

Cardiovascular symptoms Some people taking liraglutide will notice a slight increase in resting heart rate, about 2 to 3 beats per minute

The microneedle technology, which involves applying an ultra-small 1cm patch to the arm or abdomen, represents an advanced formulation that significantly enhances user convenience over traditional obesity treatments

816 pounds over 16 weeks, often with more dramatic visual change than the scale suggests